Qiagen Nv earnings were $373.4M for the trailing 12 months ending Jun 30, 2025, with 466.7% growth year over year. The latest QGEN earnings report on Jun 30, 2025 announced Q2 2025 earnings of $96.3M, up 6.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, QGEN reported annual earnings of $83.6M, with -75.5% growth.
QGEN past earnings growth
How has QGEN's earnings growth performed historically?
On QGEN's earnings call on Invalid Date, Qiagen Nv (NYSE: QGEN) reported Q2 2025 earnings per share (EPS) of $0.44, up 153.01% year over year. Total QGEN earnings for the quarter were $96.25 million. In the same quarter last year, Qiagen Nv's earnings per share (EPS) was -$0.83.
As of the last Qiagen Nv earnings report, Qiagen Nv is currently profitable. Qiagen Nv's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $373.39 million, a 413.63% increase year over year.
What was QGEN's earnings growth in the past year?
As of Qiagen Nv's earnings date in Invalid Date, Qiagen Nv's earnings has grown 466.67% year over year. This is 456.38 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 10.28%. QGEN earnings in the past year totalled $373.39 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.